Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rosiglitazone in HIV Lipoatrophy
NCT00367744Phase 2Completed
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Start
- Jul 2006
- Primary completion
- Dec 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of rosiglitazone in HIV-associated lipoatrophy, sponsored by National Institute of Allergy and Infectious Diseases. Started Jul 2006; status: completed.
02
Drugs
rosiglitazone
03
Conditions
HIV-associated lipoatrophy
Beyond the preview
Go deeper on NCT00367744.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00367744.